相关实验视频
Updated: Sep 10, 2025

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
16.1K
降低血小板聚合和血细胞因子水平缓解与代谢功能障碍相关的渐进性脂肪性肝病 (MASLD)
Tobias Harm1, Anne-Katrin Rohlfing1, Jessica Kristin Henes1
1Department of Cardiology and Angiology, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
Journal of inflammation research
|August 27, 2025
概括
抗血小板治疗可以减少与代谢功能失调相关的脂肪性肝病 (MASLD) 的特征. 这项研究发现血小板聚合减少与肝脏脂肪,体积和铁的改善有关,这表明MASLD的新治疗途径.
科学领域:
- 肝病学
- 心脏病学
- 血栓形成
背景情况:
- 在代谢综合征和冠状动脉疾病 (CAD) 患者中,代谢功能障碍相关的脂肪性肝病 (MASLD) 很常见.
- MASLD是肝脏疾病的主要原因,并对心血管疾病有很大影响.
- 增强的血小板聚合与脂肪肝炎有关,抗血小板治疗是潜在的治疗策略.
研究的目的:
- 研究抗血小板治疗对MASLD患者肝脂肪,肝体积和铁沉积的影响.
- 探索血小板功能,全身炎症和MASLD进展之间的关系.
- 描述MASLD背后的血栓炎症机制.
主要方法:
- 这是一项前性研究,涉及51名2型糖尿病和/或肥胖症患者 (BMI≥30).
- 使用磁共振成像 (MRI) 评估肝脏脂肪,肝脏体积和铁在基线和六个月.
- 检测出活体血小板功能和血细胞因子水平.
主要成果:
- 血小板反应性增加与肝脏脂肪,铁沉积和肝脏体积的增加有关.
- 抗血小板治疗与肝脏体积和铁积累的减少相关.
- MASLD的进展与血脂障碍,血小板过敏以及高水平的促炎和促纤维化基因有关.
结论:
- 血小板聚合的减少与MASLD特征的减弱有关.
- 抗血小板治疗可能会降低MASLD的促炎和促纤维信号.
- 评估血小板反应性和特定化学因子可以促进MASLD的理解和治疗.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
1.0K
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
6.7K
相关概念视频
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K